BI 905681

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 905681, covering 2023-11-29 to 2023-11-29. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread [Phase 1]

See pricing